EGENESIS
EGenesis operates as a biotechnology company. The Company focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs. eGenesis serves patients worldwide.
EGENESIS
Industry:
Biopharma Biotechnology Genetics Life Science Medical
Founded:
2014-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.egenesisbio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
265 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Global Site Tag Microsoft Exchange Online
Similar Organizations
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-05-20 | ICBiotec | ICBiotec acquired by EGenesis | N/A |
Investors List
Alta Partners
Alta Partners investment in Series C - EGenesis
Invus
Invus investment in Series C - EGenesis
ARCH Venture Partners
ARCH Venture Partners investment in Series C - EGenesis
Catalio Capital Management
Catalio Capital Management investment in Series C - EGenesis
Wellington Partners
Wellington Partners investment in Series C - EGenesis
Khosla Ventures
Khosla Ventures investment in Series C - EGenesis
Leaps by Bayer
Leaps by Bayer investment in Series C - EGenesis
Fresenius Medical Care
Fresenius Medical Care investment in Series C - EGenesis
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series C - EGenesis
Polaris Partners
Polaris Partners investment in Series C - EGenesis
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-19 | eGenesis Promotes Michael Curtis, Ph.D., to Chief Executive Officer |
| 2022-04-04 | eGenesis Appoints Eliezer Katz, M.D., FACS, as Chief Medical Officer |
Official Site Inspections
http://www.egenesisbio.com Semrush global rank: 4.85 M Semrush visits lastest month: 1.83 K
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "EGenesis"
eGenesis | About Us
OUR MISSION. eGenesis is a biotechnology company committed to using its multiplex gene …See details»
eGenesis | Our Culture | The People Behind the Science
Working toward a single ambition. We are harnessing the power of teamwork toward a single …See details»
eGenesis, Inc. | LinkedIn
EGenesis, Inc. Biotechnology Research Cambridge, MA 10,690 followers Developing human-compatible organs for transplantation.See details»
EGenesis - Crunchbase Company Profile & Funding
Contact Email [email protected] EGenesis is a biotechnology company developing solid organ and therapeutic cell transplantation to treat diseases. It …See details»
eGenesisBio, Inc. - MassBio
EGenesisBio, Inc. Life Sciences | Agricultural / Industrial Biotechnology. Cambridge, MA 617 …See details»
eGenesis, Inc.: Culture | LinkedIn
EGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene …See details»
Luhan Yang | Speaker - TED
Why you should listen. With the mission to translate scientific innovation into a life-saving …See details»
eGenesis Company Profile - Office Locations, Competitors, …
EGenesis has 5 employees at their 1 location and $265 m in total funding,. See insights on …See details»
eGenesis Presents Preclinical Data Demonstrating Recipient …
CAMBRIDGE, Mass., Oct. 26, 2023 (GLOBE NEWSWIRE) -- eGenesis, a biotechnology …See details»
eGenesis | Our Approach | Producing Human-compatible Organs
Our goal is to create an unlimited supply of safe and effective HuCo™ organs and cells for …See details»
News and Press - T1D Fund: A Breakthrough T1D Venture
Mar 2, 2021 Learn more at egenesisbio.com. Contacts: Investors John Grimaldi Burns …See details»
eGenesis - Overview, News & Similar companies | ZoomInfo.com
EGenesis contact info: Phone number: (617) 941-7500 Website: www.egenesisbio.com What …See details»
eGenesis Announces Publication in Nature of Landmark Preclinical …
Oct 11, 2023 The donor kidneys evaluated in this study carried three types of edits: (1) knock …See details»
eGenesis Announces Publication in Nature of Landmark Preclinical …
Cambridge, Mass. (Oct 11, 2023) – eGenesis, a biotechnology company developing human …See details»
eGenesis Announces World’s First Successful Transplant of …
Mar 21, 2024 The eGenesis donor kidney (EGEN-2784) used for this procedure is the …See details»
eGenesis Presents New Data on Long-Term Survival in Preclinical …
Jun 5, 2023 The company’s platform is the only technology of its kind to address both viral …See details»
eGenesis and OrganOx Announce Successful Use of a Genetically ...
CAMBRIDGE, Mass., January 18, 2024--eGenesis and OrganOx Announce Successful Use of …See details»
eGenesis and OrganOx Announce Successful Use of a Genetically ...
Jan 18, 2024 CAMBRIDGE, Mass.--(BUSINESS WIRE)--eGenesis, a biotechnology company …See details»
eGenesis | News and Media
Dec 26, 2017 EGENESIS CAMBRIDGE OFFICE (HQ) 101 Cambridgepark Drive Suite 200 …See details»